Companies: 10,795·Total market cap: $144.5T
Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc.

FENCNASDAQHealthcare● Active
$8.90
+$0.20(+2.30%)
Market Cap$254362223
P/E Ratio
52W High$10.45
52W Low$5.65
Overview

Fennec Pharmaceuticals Inc. (FENC) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · FENC · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-0.31fenc eps ttm · fenc earnings per shareEarnings history
PE Ratio (TTM)fenc pe ratio ttm · fenc price to earningsPE Ratio deep dive
Revenue (TTM)$51.0Mfenc revenue ttm · fenc annual revenueFull revenue history
Dividend YieldNo Dividenddoes fenc pay dividends · fenc dividend yieldDividend history
Shares Outstanding28.6Mfenc shares outstanding · fenc floatShares outstanding history
Next EarningsAug 13, 2026Est.fenc earnings date · fenc next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$44.6M▼ 6.09% YoY
202320242025
fennec pharmaceuticals inc. revenue · fenc revenue 2025
FY 2025Net Income-$9.7M▼ 2134.17% YoY
202320242025
fennec pharmaceuticals inc. net income · fenc profit 2025
FY 2025EPS$-0.36▼ 2150.00% YoY
202320242025
fenc eps · fennec pharmaceuticals inc. earnings per share 2025
TTM:Revenue: $51.0MNet Income: -$8.4MEPS: $-0.31View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy7 analystsis fenc a buy · fenc analyst rating
Strong Buy
0
Buy
7
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$16.00Low
$8.90Current
$17.00Avg Target91.01% upside
$18.00High
fenc price target · fenc 12 month forecast

Total: 7 · Buy rate: 100.0%

The FENC analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $17.00, representing +91.01% upside from the current price of $8.90.

Stock Performance

Full History
1D+2.30%
1W-10.64%
1M+28.43%
3M+15.58%
YTD+15.58%
1Y+7.88%
5Y+27.69%

About Fennec Pharmaceuticals Inc.

CEOJeffrey S. Hackman
IPO DateSep 15, 2017
Employees32
CountryUS

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading investigational drug in clinical development is PEDMARK, a specialized formulation of sodium thiosulfate. This treatment i…

what is fennec pharmaceuticals inc. · fenc stock overview · fennec pharmaceuticals inc. company profile · who is fennec pharmaceuticals inc. ceo · fenc NASDAQ · fennec pharmaceuticals inc. headquarters · fennec pharmaceuticals inc. business segments

About Stock Overview & Key Data

Fennec Pharmaceuticals Inc. (FENC) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 15, 2017. As of the latest trading session, FENC stock price is $8.90, with a market capitalization of $254.4M. The stock has returned +7.88% over the past 12 months and +15.58% year-to-date.

According to 7 Wall Street analysts, the consensus rating for Fennec Pharmaceuticals Inc. stock is Buy, with an average 12-month price target of $17.00. In fiscal year 2025, Fennec Pharmaceuticals Inc. reported revenue of $44.6M and net income of -$9.7M. For detailed data — including Fennec Pharmaceuticals Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Fennec Pharmaceuticals Inc. (FENC) stock price is $8.90. The stock is traded on NASDAQ under the ticker symbol FENC. The 52-week range is $5.65 – $10.45.

FENC stock priceFENC quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice